Introduction
The design andd evelopment of reproducible, environmentally benign and economical synthetic routes to drugs is of paramounti mportance in the pharmaceuticali ndustry,a nd, in this context,c ontinuous-flows ynthesis is receiving increasing attention. [1] [2] [3] As ar esult,i nr ecent years, many new flow-based routes have been designed towards commercially available active pharmaceutical ingredients. [4, 5] We herein report an efficient chemoenzymatic flow synthesis of captopril [(S)-1-[(S)-3-mercapto-2-methylpropanoyl]pyrrolidine-2-carboxylic acid, 5,S cheme 1].C aptopril is an angiotensin-converting enzyme (ACE) inhibitor and was discovered and developed at E. R. Squibb &S ons Pharmaceuticals in the 1970s, and is still awidely prescribed drug for the treatment of hypertension.
Our flow-based synthetic route to obtain captopril includes af irst biocatalyzedh eterogeneousr egio-and stereoselective oxidation reaction startingf rom ac heap prochiral diol (2-methyl-1,3-propandiol, 1) [6, 7] followed, after isolation of carboxylic acid 2,b yt hree sequential chemical steps. The biocatalyzed flow oxidation offers an efficient alternative for environmentally benigno xidations in answer to the criticale conomic and environmental issues that urgentlyd emandg reener,m ore atom-efficient and scalableo xidation methods. [8, 9] The oxidation wasp erformed using Acetobacter aceti MIM 2000/28; [10] [11] [12] this strain is ablet oc ompletely convert the substrate into (R)-3-hydroxy-2-methylpropanoic acid (2)w ith an excellent ee (96-97 %) using ac onventionalb atch-mode biotransformation. To exploit all the advantages of performing (bio)catalyzed reactions in flow,i np articulart he high local concentrationo ft he biocatalyst, [13] [14] [15] [16] A. aceti has been immobilized as dried alginate-entrapped cells, that are economical, easyt op repare and can be efficiently used in ap acked bed column. [17] Also, importantly, the use of whole cells in biocatalytic oxidation has the great advantage of not requiring an additional cofactor regeneration system.
The following three chemical steps that yield captopril under continuous flow conditions are depicted in Scheme 1. To achieve this continuous-flow synthesis, the reactions have been designeds ot hat the excesso fr eagents and reaction byproducts from each reactionw ere compatible with the downstream reactions, in order to performs teps in sequence without breaks in the workflow and manipulation. The risks associated with exothermic reactions and quenches (i.e.,t he use and neutralization of thionyl chloride) were mitigated owing to two of the advantages of continuous flow over batch syntheThe chemoenzymatic flow synthesis of enantiomericallyp ure captopril, awidely used antihypertensive drug, is accomplished startingf rom simple, inexpensive, and readily available reagents. The first step is ah eterogeneousb iocatalyzedr egioand stereoselective oxidation of cheap prochiral 2-methyl-1,3-propandiol, performed in flow using immobilized whole cells of Acetobacter aceti MIM 2000/28, thus avoiding the use of aggressivea nd environmentally harmful chemical oxidants. The isolation of the highly hydrophilic intermediate (R)-3-hydroxy-2-methylpropanoic acid is achieved in-line by using ac atchand-release strategy.T hen, three sequential high-throughput chemicals teps lead to the isolation of captopril in only 75 min. In-line quenching and liquid-liquids eparation enableb reaks in the workflow and other manipulations to be avoided. sis:1 )only as mall amount of material relative to the overall output of the system is utilized at any given time, and 2) the large surface-area-to-volume ratios that allow precise reaction control through rapid heat transfer and mixing. Moreover,i nline liquid-liquid extractions safely neutralized and removed problematic reagents andb y-products.
Results and Discussion
First, commercially availabled iol 1 (1 gL À1 in 20 mm acetate buffer,p H6)w as successfully oxidized with dried alginate beads of Acetobacter aceti MIM 2000/28 with highe nantioand regioselectivity.T he immobilized cells were prepared according to ap rotocolr ecently reported by us, [17] packed into ag lass column( inner diameter 15 mm) and swelled by flowing buffer through the columnu ntil their volume tripled. No release of catalysti nt he exiting flow stream was observed. The oxygen supply,e ssential for cofactor recycling, was ensured by means of as egmented air-liquid flow stream (for details, see the Experimental Section) formed before contact with the immobilized biocatalyst (Scheme 2).
The reactionr eached 95 %c onversion in only 10 min with an excellent ee (96-97%), as determined by chiral gas chromatography.T he stabilityo ft he biocatalyst under continuous work was assessed by performing the biotransformation under the conditions reported in the Experimental Section. Using 400 mg of immobilizedb iocatalyst, at otal volume of approximately 50 mL was collected. Samples collected at different times were analyzed by HPLC and the results obtained in terms of conversion werec omparableo ver time, indicating good stabilityu nder continuous work conditions. The maximum conversion ( % 95 %) was observed for the first 35 mL of collected solution. Then, the conversion slowly decreased to 80 %i nt he following fractions.T herefore, the use of dried alginate beads in flow offers good stability overt he time, giving 95 %c onversion for approximately 10 ho fc ontinuous work. However,t he buffer flow stream, even if characterized by low ionic strength (20 mm), might interfere with the alginateb ead structure, which could slowly releaset he biocatalyst and consequently decrease the conversion.
Attempts to perform in-line acidification and extraction with an organic solvent( e.g.,E tOAc) using al iquid-liquids eparator were not successful due to the high hydrophilicity of the obtained carboxylic acid 2.C onsequently,w ee xploited ac atchand-release strategy using ac olumnp acked with Ambersep 900 OH resin that trapped the acid, leaving unreacted starting material in the exiting flow stream.C ompound 2 was then released from the resin by using 1 n HCl and lyophilized.
Then, startingf rom the isolated compound 2,w es tudied the chlorination reaction with thionyl chloride with heating in ap ressurized system to effect both the formation of the acid chloridea nd the direct chlorination of the primary alcohol (Scheme 3). A2 00 psi backpressure regulator (BPR) was used to prevento utgassing. The possibility of conducting such an exothermic reactionu nder heatingc onditions demonstrates one of the operational advantages and capabilities of continuous flow synthesis over analogousbatch processes that require cooling during the addition of thionyl chloride.
The reaction was tested in anhydrous toluene, THF,a nd CH 2 Cl 2 ;t he reaction proceeded similarly with all the selected solvents. Therefore, toluene was selected and a1m solution of compound 2 was used. An excess of thionyl chloride (3 equiv, 3 m solution in toluene) was necessary to drive the reaction to completion.Acatalytic amount of imidazole and 10 %D MF (v/v) were added to the solution of 2.T he use of DMF has ad ouble effect:f irst, it favoredt he reaction due to the formation of the Vilsmeierreagent and, second, it increased the solubility of the startingm aterial in toluene. Different reactionc onditions were then tested and they are summarized in Table 1 . The outcome was monitored by 1 HNMR spectroscopya fter evaporation of the solvent. If no complete conversion was observed, the startingm aterial 2 and/or the acid chloride (without substitution of the hydroxy group) were identified as the only impurities. We also tried the reaction using only DMF to Scheme2.Biocatalyzed heterogeneous oxidation of prochiral 2-methyl-1,3-propandiol (1)a nd in-line purification of the product through ac atch-andrelease protocol.
Scheme3.The chlorination reaction using a1 0mLr eactorc oil. BPR:200 psi. Solvent, temperature and residencet ime were optimized as summarized in Ta ble 1. (Table 1 , entries 6a nd 7) and observed complete conversion at 100 8Ci n3 0min.
Intermediate 3 was then submitted to amide coupling with l-proline (Scheme4). Because the final goalw as to have all the synthetic steps in-line, withoutabreak in the workflow, we decided to use for this reaction the same solvent as in the previous step.
Thus, 3 was dissolved in toluene( 1m solution), mixed with an aqueous basic (NaOH, 3equiv) solution of l-proline (2 m solution, 2equiv) and flowed into a2mL perfluoroalkoxy alkane (PFA) reactorcoil. The reactionwas performed at room temperature, without cooling, and was rapid, giving full conversion within only 1min of residence time. In-line acidification to pH 2f ollowedb yaliquid-liquid separation using aZ aiput separator wereperformed, affording the desired product 4.
The final step was the nucleophilic substitution of the chlorine with the thiol group (Scheme 5). Again, we used toluene as an organic solvent and the reactionw as studied in ab iphasic system toluene/degassed water,u sed to reduce the possible formation of oxidized byproducts.
To perform the substitution, an excess of NaSH (3 equiv) was efficiently used. An in-line acidification followed by al iquidliquid separation allowed captopril to be obtained from the organic phaset hat was evaporated and analyzed by 1 HNMR spectroscopy.T emperature and residence time were optimized and the results are summarized in Ta ble 2. The reaction was complete in 30 min at 125 8C(Ta ble2,e ntry 4).
Once the reactions weres eparatelyo ptimized, we next developedac ontinuous multistep productiono fc aptopril that would be sufficiently robust for multiple hours of continuous work (Scheme 6). We assembled the system such that the product stream from the chlorination reaction, obtained using the conditions reportedi nT able 1( entry 3), was immediately submitted to the coupling reaction in at oluene/waterb iphasic system,a sd escribed above.T ot his end, first we evaluated the amount of NaOH necessary to neutralize the excessa cid from the chlorination step. The T-junction was cooled to 0 8Cf or the neutralization and, in this way,t he uncontrollede xothermic neutralization and the release of large quantities of HCl vapors were avoided. In this set-up, the residence time for the coupling reaction in the 2mLr eactor coil was approximately 3min (Scheme6). After separation of the two phases,t he exiting organics olution of compound 4 was collected in av ial, acting as areservoir,and then directly used for the substitution reaction. The solutionw as pumped into a1 0mLr eactor coil after mixingw ith the solution of NaSH in degassed water and heated at 125 8C.
After in-line acidification, extraction ande vaporation of the solvent, the resulting crude materialw as purified by column chromatography to yield pure captopril as aw hite solid. The 1 HNMR spectrum and the opticalr otationm atched those reportedi nt he literature. [18] Scheme4.The coupling reaction using a2mL reactor coil. Pressure:200 psi.
Scheme5.The nucleophilic substitution using a10mLr eactorcoil. Pressure: 200 psi. 
Conclusions
The multistep flow synthesis presented here enabled captopril to be obtained in an overall yield of 50 %a fter crystallization. Biocatalytic oxidation facilitatedt he conversion of ap rochiral substrate into ac hiral intermediate with high enantiomeric excess. Three chemicalt ransformationsw ere performed without isolation of the intermediates. The separation of co-products, by-products, and excessr eagents was achievedi n-line. These results clearly highlightthe benefits of performing multistep chemical synthesis in af low environment. As af urther advantage,o ur synthetic protocol benefits from the use of an environmentally friendly biocatalytic oxidation, avoiding the use of toxic chemical oxidants. The bioprocess might be further linked to the chemical transformationsb yo ptimizing the extraction of acid (2)w ith organic solvents, for example, using specific organic-acid-complexing carriers. [19] In light of af uture scale-up, whereas none of the chemical steps have foreseen limitations, furtherefforts should be directed toward increasing the productivity of the first biocatalyzed step, which at present represents ab ottleneck in the process. The new proposed protocol for the synthesis of captopril represents ap owerful integration of biocatalysis andflow-chemistry technology.
Experimental Section
All reagents and solvents were purchased from Sigma-Aldrich. The continuous flow reactions were performed using ac ommercial R2C/R4 flow reactor (Vapourtec, Bury St. Edmunds, Suffolk, UK) equipped with Omnifit glass columns (15 mm i.d. 100 mm length) and PFAr eactor coils (2 and 10 mL, respectively). The R2C unit is the pumping unit that contains two adapted Knauer pumps, which are able to pump highly concentrated and corrosive acids. R4 is the heating unit with four heating positions. The additional HPLC pumps necessary to perform the overall synthesis were provided by another R2 + /R4 flow reactor (Vapourtec) and by two external pumps (ThalesNano). The temperature sensor sits on the wall of the PFAt ubing. The pressure was controlled by using two 100 psi BPRs. In-line liquid-liquid extractions were performed using aZ aiput separator. 1 HNMR and 13 CNMR spectra were recorded with aV arian Mercury 300 (300 MHz) spectrometer. Chemical shifts (d)a re expressed in ppm, and coupling constants (J)a re expressed in Hz. The molar conversion of the biotransformation was determined by HPLC analysis using aL una NH 2 100 column (250 mm 4.6 mm, particle size 5 mm, Phenomenex, Aschaffenburg, Germany) and aB iorad refractor index detector with an acidic aqueous KH 2 PO 4 buffer (20 mm,p H2.7) as the mobile phase (flow rate 0.2 mL min À1 ). The samples (40 mL) were injected as soon as collected and without further treatment. The enantiomeric composition of 2 was determined by gas chromatographic analysis of the corresponding methyl ester [methyl (R)-3-hydroxy-2-methylpropionate: t r = 3.6 min],o btained after treatment with diazomethane, using ac hiral capillary column (diameter 0.25 mm, length 25 m, DMePeBeta-CDX-PS086, MEGA, Legnano, Italy). Optical rotation determinations were performed using aJasco P-1010 spectropolarimeter coupled with aHaake N3-B thermostat. MS analyses were performed on aV arian 320-MS triple quadrupole mass spectrometer with an electrospray ionization (ESI) source. Microanalyses (C, H, N) were within AE 0.4 %o ft heoretical values. ), pH 5; 20 mL].A fter growth for 24 h( shaking at 150 rpm, 28 8C), the liquid culture was entirely used to inoculate a1LE rlenmeyer baffled flask containing GLYm edium (150 mL). Flasks were grown for 24 ha t2 8 8C, with shaking at 150 rpm.
Strain Preparation

Preparation of Dry Alginate Beads
Gel beads were prepared by ionotropic gelation, by following ap rotocol previously developed by us: [17] a4%( w/v)s odium alginate solution was prepared in distilled water and stirred until ah omogeneous clear solution was formed. The solution was allowed to settle for 2h in order to eliminate the air bubbles. The alginate solution was then gently mixed in a1 :1 (w/w) ratio with as uspension of A. aceti cells (40 OD mL À1 )i ns odium acetate buffer (20 mm, pH 6). The resulting mixture was then pumped dropwise into as lightly agitated CaCl 2 solution (0.2 m). Calcium alginate beads were agitated for 20 min, then filtered, washed with deionized water and dried at 25 8Cf or 16 h.
Synthesis of (R)-3-Hydroxy-2-methylpropanoic Acid (2)
Dry alginate beads (400 mg) were packed into ag lass column (i.d. 15 mm) and swelled until their volume tripled by flowing acetate buffer (20 mm,p H6)t hrough the column (flow rate:4 00 mLmin À1 , 60 min). The final volume of the bed was 5.1 mL. Air was delivered at 17 psi;i ts flow was measured using the method described in Ref. [20] .T oe nsure ac onstant flow,aBRP (40 psi)w as applied before the air tank. An aqueous solution of 1 (1 gL À1 ,4 0mL) was pumped at 60 mLmin
À1
,j oining the airflow at the T-junction, before entering the column in which the oxidation occurs in approximately 10 min. The exiting flow stream was directed into adecompression column. AB PR (5 psi)e nsured ac onstant and controlled flow of aqueous phase leaving the column. The aqueous stream was directed into ac olumn filled with Ambersep 900 OH resin (2 g) and, after washing the column with water (20 mL, 0.5 mL min À1 ), the trapped acid was released by flowing HCl (1 n, 5mL). After lyophilization, compound 2 was isolated as pale yellow oil (42 mg).
To obtain al arger amount of 2,1 .6 go fa lginate beads were used, with ar eactor volume of 20 mL. At this scale, 170 mg of compound 2 was isolated (91 %y ield). À ; [21] HPLC analysis: 1, t r = 22 min; 2, t r = 18 min.
Synthesis of (R)-3-Chloro-2-methylpropanoyl Chloride (3)
As olution of 2 (52 mg, 0.5 mmol) was prepared in anhydrous toluene (410 mL). Imidazole (3.5 mg, 0.1 equiv) and DMF (50 mL) were added to the solution. As econd solution of thionyl chloride (125 mL, 3.5 equiv) was prepared in anhydrous toluene (375 mL).
The two solutions were mixed into aT -piece and flowed through a1 0mLr eactor coil according to the conditions reported in Table 1 . A2 00 psi backpressure regulator was applied to the 
Synthesis of (S
As olution of compound 3 (70 mg, 0.5 mmol) in toluene (0.5 mL) was prepared. As econd solution of l-proline (115 mg, 2equiv) and NaOH (60 mg, 3equiv) was prepared in water (0.5 mL). The two solutions were flowed at at otal rate of 2mLmin À1 through a2mL reactor coil, that had been washed with am ixture of toluene and water,a tr oom temperature. The aqueous phase was acidified to pH 2b yi ntroducing af low of HCl (6 n,1mL min À1 )a nd the resulting biphasic system was mixed using aT -junction into an EtOAc stream (1 mL min À1 )t op erform in-line extraction. The two phases were separated in-line using aZ aiput liquid-liquid separator.A 200 psi backpressure was applied to the system. The organic solvent was dried over anhydrous Na 2 SO 4 and evaporated under reduced pressure to yield 4 as ac rude solid, which was analyzed by 
As olution of compound 4 (22 mg, 0.1 mmol) in toluene (0.1 mL) was prepared. Asecond solution of NaSH (21 mg, 3equiv) was prepared using degassed water (0.1 mL). The two solutions were flowed through a1 0mLr eactor coil. A2 00 psi backpressure was applied to the system. Reaction time and temperature were optimized, as reported in Ta ble 2. The aqueous phase was acidified at pH 2b yi ntroducing af low of HCl (2 n)a nd the resulting biphasic system was mixed using aT -junction into an EtOAc stream to perform in-line extraction. The two phases were separated in-line using aZ aiput liquid-liquid separator.T he organic solvent was dried over anhydrous Na 2 SO 4 and evaporated under reduced pressure to yield 5 as ap ale yellow crude solid, which was analyzed by Three-Step Continuous-Flow Synthesis of Captopril (5) As olution of 2 (156 mg, 1.5 mmol) in anhydrous toluene (1.23 mL) was prepared. Imidazole (10.5 mg, 0.1 equiv) and DMF (150 mL) were added to the solution. As econd solution of thionyl chloride (375 mL, 3.5 equiv) was prepared using anhydrous toluene (1.12 mL). The two solutions were flowed through a1 0mLc oil reactor that was maintained at 110 8C, with ar esidence time of 30 min (total flow rate 0.33 mL min
À1
). Then, the exiting flow was merged at aT -junction with an aqueous solution (1.5 mL) of l-proline (2 equiv) and NaOH (7 equiv). This then entered a2mL reactor coil, maintained at room temperature with ar esidence time of 3min (total flow rate 0.66 mL min
). The aqueous phase was acidified to pH 2b ya dding af low stream of HCl (6 n,0 .33 mL min À1 ) and the resulting biphasic system was mixed using aT -junction into an EtOAc stream (0.33 mL min À1 )t op erform an in-line extraction. The two phases were separated in-line using aZ aiput liquidliquid separator.T he organic phase was collected in av ial acting as as ubstrate reservoir for the final nucleophilic substitution reaction. The organic phase was pumped and mixed with as olution of NaSH (c = 1.5 m,3equiv) in degassed water,a nd entered a1 0mL coil reactor maintained at 125 8Cf or 30 min (total flow rate 0.66 mL min
). A2 00 psi backpressure was added to the whole system. The exiting flow was then acidified to pH 1w ith HCl (2 n) and ac ontinuous extraction with the Zaiput liquid-liquid separator was performed. The organic solvent was dried over anhydrous Na 2 SO 4 and evaporated under reduced pressure to yield ac rude material that was purified by column chromatography (dichloromethane/methanol 98:2) to yield captopril, which was crystallized from ethyl acetate/hexane (1:1, total volume 1mL; 160 mg, 50 %).
